NDC 58160-827

Menveo

Meningococcal (groups A, C, Y And W-135) Oligosaccharide Diphtheria Crm197 Conjugate Vaccine

Menveo is a Intramuscular Injection, Solution in the Vaccine category. It is labeled and distributed by Glaxosmithkline Biologicals Sa. The primary component is Neisseria Meningitidis Group A Capsular Oligosaccharide Diphtheria Crm197 Protein Conjugate Antigen; Neisseria Meningitidis Group C Capsular Oligosaccharide Diphtheria Crm197 Protein Conjugate Antigen; Neisseria Meningitidis Group W-135 Capsular Oligosaccharide Diphtheria Crm197 Protein Conjugate Antigen; Neisseria Meningitidis Group Y Capsular Oligosaccharide Diphtheria Crm197 Protein Conjugate Antigen.

• Product ID: 58160-827_65d17888-a61e-4c20-8b41-6b08327eb7c1
• NDC: 58160-827
• Product Type: Vaccine
• Proprietary Name: Menveo
• Generic Name: Meningococcal (groups A, C, Y And W-135) Oligosaccharide Diphtheria Crm197 Conjugate Vaccine
• Dosage Form: Injection, Solution
• Route of Administration: INTRAMUSCULAR
• Marketing Start Date: 2022-12-09
• Marketing Category: BLA /
• Application Number: BLA125300
• Labeler Name: GlaxoSmithKline Biologicals SA
• Substance Name: NEISSERIA MENINGITIDIS GROUP A CAPSULAR OLIGOSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; NEISSERIA MENINGITIDIS GROUP C CAPSULAR OLIGOSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; NEISSERIA MENINGITIDIS GROUP W-135 CAPSULAR OLIGOSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; NEISSERIA MENINGITIDIS GROUP Y CAPSULAR OLIGOSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN
• Active Ingredient Strength: 10 ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL
• Pharm Classes: Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Inactivated Meningococcal Vaccine [EPC], Inactivated Meningococcal Vaccine [EPC], Inactivated Meningococcal Vaccine [EPC], Inactivated Meningococcal Vaccine [EPC], Meningococcal Vaccines [CS], Meningococcal Vaccines [CS], Meningococcal Vaccines [CS], Meningococcal Vaccines [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS]
• NDC Exclude Flag: N
• Listing Certified Through: 2023-12-31

Packaging

NDC 58160-827-30

10 VIAL in 1 CARTON (58160-827-30) > .5 mL in 1 VIAL (58160-827-03)

• Marketing Start Date: 2022-12-09
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details

NDC Crossover Matching brand name "Menveo" or generic name "Meningococcal (groups A, C, Y And W-135) Oligosaccharide Diphtheria Crm197 Conjugate Vaccine"

NDC	Brand Name	Generic Name
58160-827	Menveo	Meningococcal (Groups A, C, Y and W-135) Oligosaccharide Diphtheria CRM197 Conjugate Vaccine
58160-955	Menveo	Meningococcal (Groups A, C, Y and W-135) Oligosaccharide Diphtheria CRM197 Conjugate Vaccine